NEW YORK (GenomeWeb) – Horizon Discovery Group and Abcam today announced a licensing and supply agreement that gives Abcam exclusive access to more than 1,800 human diploid and haploid cell lines from Horizon's X-MAN collection. 

The cell lines will help in the validation of Abcam's existing monoclonal and polyclonal antibodies marketed to researchers, the firms said, and Horizon will develop additional haploid cell lines to validate new antibodies from Abcam. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.